Combined anticoagulant and antiplatelet therapy is associated with an improved outcome in hospitalised patients with COVID-19: a propensity matched cohort study
Guardado en:
Autores principales: | Pascale Salameh, Kamal Matli, Nibal Chamoun, Georges Ghanem, Aya Fares, Victor Zibara, Soad Al-Osta, Rabih Nasrallah, Jacques Mokhbat |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6bce9158225943309bc037cfe4ba6e11 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Antiplatelet/anticoagulant agents and chronic subdural hematoma in the elderly.
por: Pasquale De Bonis, et al.
Publicado: (2013) -
Impact of anticoagulation and antiplatelet drugs on surgery rates and mortality in trauma patients
por: Felix M. Bläsius, et al.
Publicado: (2021) -
A review of potential harmful interactions between anticoagulant/antiplatelet agents and Chinese herbal medicines.
por: Hsin-Hui Tsai, et al.
Publicado: (2013) -
Oral Anticoagulant and Antiplatelet
Therapy for Cervical Artery Dissection: A Meta-Analysis of Clinical Trials
por: Sheng-Lin Ye MD, et al.
Publicado: (2021) -
Stroke of antiplatelet and anticoagulant therapy in patients with coronary artery disease: a meta-analysis of randomized controlled trials
por: Qiao Yu Shao, et al.
Publicado: (2021)